Open Menu icon
JOIN
SEARCH
Home
Press Releases

Biosimilars Council Press Releases

Press Releases
  • Press Releases

AAM Applauds Senate Bill to Protect Patient Access to Affordable Medicines
  • Press Releases

AAM Comments on End of Year Funding Bill
  • Press Releases

Medicare Plans Continue Trend of Restricting Generic Drugs
  • Press Releases

AAM & Biosimilars Council Statement on Presidential Election
  • Press Releases

$2 Generics List Not the Solution
  • Press Releases

AAM Urges Congress to Pass Key Bills Considered by the Senate HELP Committee This Week
  • Press Releases

John Murphy Named President and CEO of AAM
  • Press Releases

40 Years of Hatch-Waxman – Trillions in Savings for Patients
  • Press Releases

Generic Medicines Increase Patient Access More Than Government Negotiated Price Controls
  • Press Releases

Statement Regarding Senate Judiciary Committee Markup of the PREVAIL Act and the PERA Act
  • Press Releases

AAM and the Biosimilar Council Host Patent Abuse Congressional Briefing: What’s Truly Preventing Low-Cost Medicines from Getting to Patients: A Look at the Broken Patent System
  • Press Releases

Generic and Biosimilar Medicines Save $445 Billion in 2023
Load More
JOIN
SEARCH